Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study
- 1 August 2000
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 356 (9231) , 701-707
- https://doi.org/10.1016/s0140-6736(00)02627-1
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Evolving spectrum of mortality and morbidity in SLELupus, 1999
- Morbidity and Mortality in Systemic Lupus Erythematosus During a 5-Year Period: A Multicenter Prospective Study of 1,000 PatientsMedicine, 1999
- Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient miceProceedings of the National Academy of Sciences, 1999
- Participation of the CD69 Antigen in the T‐Cell Activation Process of Patients with Systemic Lupus ErythematosusScandinavian Journal of Immunology, 1998
- Prevention of development of autoimmune disease in BXSB mice by mixed bone marrow transplantationProceedings of the National Academy of Sciences, 1997
- Genetic dissection of lupus nephritis in murine models of SLE.Journal of Clinical Immunology, 1997
- Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin‐10: Interferon‐γ–secreting cells in the peripheral bloodArthritis & Rheumatism, 1996
- The role of transforming growth factor beta in the generation of suppression: an interaction between CD8+ T and NK cells.The Journal of Experimental Medicine, 1994
- Therapy of Lupus NephritisNew England Journal of Medicine, 1986
- Why do patients with lupus nephritis die?BMJ, 1985